SCHEMBL2481167

SCHEMBL2481167

NC1CCN(C(CF)CF)C1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973550 0.72
SCHEMBL3973463 0.72
Hydrochloric Acid SCHEMBL3973657 0.71
SCHEMBL3980667 0.61 THRB (0.36)
SCHEMBL1811006 0.61 GNAI3 (0.31)
SCHEMBL1700039 0.58
Hydrochloric Acid SCHEMBL1956988 0.55
SCHEMBL21379123 0.52 GPR119 (0.34)
SCHEMBL23938196 0.51
SCHEMBL23894275 0.51 L3MBTL1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376197-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2011-10-19 EP disclosed
WO-2010065824-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-06-10 WO disclosed